Alejandra de Alba Campomanes, MD
Ophthalmology · San Francisco, CANPI 1003028580
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,815 of the $1,940 with a category attached, or 93.6%. Novartis accounts for 93.6% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2021 at $1,826 and has fallen 94.8% since, to $95 in 2024.
Across 4 payments — averaging $484.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- AbbVie$95
- Carl Zeiss Meditec AG$19
- Travere Therapeutics, Inc.$11
Across 27 payments — averaging $5197.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$140K
What the payments were for
- Consulting fees$1,81594%
- Food & beverage$955%
- Education$111%
- Gifts$191%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 1 | $1,815 |
| AbbVie | 1 | $95 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Travere Therapeutics, Inc. | 1 | $11 |
How this compares
$1,940 in reported general payments places this provider in the 55th percentile of 2,513 ophthalmology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in San Francisco
- Daniel SchwartzSan Francisco$8M
- Gaurav ShahSan Francisco$620K
- Shan LinSan Francisco$374K
- H TanakaSan Francisco$238K
- Jay StewartSan Francisco$219K
- Scott SoSan Francisco$173K
- Michael BerlinWest Hollywood$5.7M
- Gilbert KlimanMenlo Park$1.5M
- Kuldev SinghStanford$1.5M
- Raymond DouglasBeverly Hills$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.